Literature DB >> 26307505

Vitamin D Status in South Africa and Tuberculosis.

Vanessa Meyer1, Tamsyn Jacki Jeffery1, Liza Bornman2.   

Abstract

According to the World Health Organisation South Africa has the third highest tuberculosis (TB) incidence in the world, with an estimated 60 % incident cases having both TB and HIV. The South African National Tuberculosis Association (SANTA) recognized the importance of nutrition in the prevention and management of TB by including feeding schemes in community outreach programs. Vitamin D enhances innate immunity against mycobacterial infection through the antimicrobial peptide, cathelicidin. We reviewed studies on vitamin D status, its link with TB, and potential use in therapy in multiethnic South Africa with sunlight as primary source of vitamin D. Ethnicity, season, disease state, latitude, and urbanization are critical factors to be considered in vitamin D supplementation for prevention and treatment of TB.

Entities:  

Keywords:  25(OH)D; Deficiency; Insufficiency; South Africa; Tuberculosis; Vitamin D

Mesh:

Substances:

Year:  2015        PMID: 26307505     DOI: 10.1007/s00408-015-9789-4

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  72 in total

1.  Vitamin D nutrient to treat TB begs the prevention question.

Authors:  Reinhold Vieth
Journal:  Lancet       Date:  2011-01-05       Impact factor: 79.321

2.  Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.

Authors:  Philip T Liu; Steffen Stenger; Dominic H Tang; Robert L Modlin
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.

Authors:  Philip T Liu; Steffen Stenger; Huiying Li; Linda Wenzel; Belinda H Tan; Stephan R Krutzik; Maria Teresa Ochoa; Jürgen Schauber; Kent Wu; Christoph Meinken; Diane L Kamen; Manfred Wagner; Robert Bals; Andreas Steinmeyer; Ulrich Zügel; Richard L Gallo; David Eisenberg; Martin Hewison; Bruce W Hollis; John S Adams; Barry R Bloom; Robert L Modlin
Journal:  Science       Date:  2006-02-23       Impact factor: 47.728

4.  Factors influencing the vitamin D status of 10-year-old urban South African children.

Authors:  Machuene A Poopedi; Shane A Norris; John M Pettifor
Journal:  Public Health Nutr       Date:  2010-08-31       Impact factor: 4.022

5.  Pulmonary tuberculosis patients with a vitamin D deficiency demonstrate low local expression of the antimicrobial peptide LL-37 but enhanced FoxP3+ regulatory T cells and IgG-secreting cells.

Authors:  Sayma Rahman; Anders Rehn; Jubayer Rahman; Jan Andersson; Mattias Svensson; Susanna Brighenti
Journal:  Clin Immunol       Date:  2014-12-12       Impact factor: 3.969

6.  The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.

Authors:  Elly Wijaya Nursyam; Zulkifli Amin; C Martin Rumende
Journal:  Acta Med Indones       Date:  2006 Jan-Mar

Review 7.  Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis.

Authors:  Kelechi E Nnoaham; Aileen Clarke
Journal:  Int J Epidemiol       Date:  2008-02       Impact factor: 7.196

8.  Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.

Authors:  Michael F Holick; Rachael M Biancuzzo; Tai C Chen; Ellen K Klein; Azzie Young; Douglass Bibuld; Richard Reitz; Wael Salameh; Allen Ameri; Andrew D Tannenbaum
Journal:  J Clin Endocrinol Metab       Date:  2007-12-18       Impact factor: 5.958

9.  Vitamin d deficiency and tuberculosis progression.

Authors:  Najeeha Talat; Sharon Perry; Julie Parsonnet; Ghaffa Dawood; Rabia Hussain
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

Review 10.  Vitamin D status and sun exposure in southeast Asia.

Authors:  Hataikarn Nimitphong; Michael F Holick
Journal:  Dermatoendocrinol       Date:  2013-01-01
View more
  2 in total

1.  Methylation of the Vitamin D Receptor (VDR) Gene, Together with Genetic Variation, Race, and Environment Influence the Signaling Efficacy of the Toll-Like Receptor 2/1-VDR Pathway.

Authors:  Vanessa Meyer; Donovan Sean Saccone; Fidele Tugizimana; Furaha Florence Asani; Tamsyn Jacki Jeffery; Liza Bornman
Journal:  Front Immunol       Date:  2017-09-11       Impact factor: 7.561

Review 2.  Barriers to HIV remission research in low- and middle-income countries.

Authors:  Theresa Rossouw; Joseph D Tucker; Gert U van Zyl; Kenly Sikwesi; Catherine Godfrey
Journal:  J Int AIDS Soc       Date:  2017-06-05       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.